| Q40106826 | A potential alpha-helix motif in the amino terminus of LANA encoded by Kaposi's sarcoma-associated herpesvirus is critical for nuclear accumulation of HIF-1alpha in normoxia |
| Q28535343 | A unique SUMO-2-interacting motif within LANA is essential for KSHV latency |
| Q39574730 | ATF3, an HTLV-1 bZip factor binding protein, promotes proliferation of adult T-cell leukemia cells |
| Q33895137 | Amplification of the angiogenic signal through the activation of the TSC/mTOR/HIF axis by the KSHV vGPCR in Kaposi's sarcoma |
| Q40051226 | An autonomous replicating element within the KSHV genome |
| Q38515827 | An overview of new biomolecular pathways in pathogen-related cancers |
| Q38854475 | Analysis of the Cullin binding sites of the E4orf6 proteins of human adenovirus E3 ubiquitin ligases. |
| Q28750291 | Angiogenesis, Kaposi's Sarcoma and Kaposi's Sarcoma-Associated Herpesvirus |
| Q36715681 | Aurora A kinase (AURKA) in normal and pathological cell division |
| Q37318235 | BC-box protein domain-related mechanism for VHL protein degradation |
| Q34245230 | Bortezomib-induced Epstein-Barr virus and Kaposi sarcoma herpesvirus lytic gene expression: oncolytic strategies |
| Q36086302 | Bub1 in Complex with LANA Recruits PCNA To Regulate Kaposi's Sarcoma-Associated Herpesvirus Latent Replication and DNA Translesion Synthesis |
| Q35943718 | Carboxyl-terminal amino acids 1052 to 1082 of the latency-associated nuclear antigen (LANA) interact with RBP-Jκ and are responsible for LANA-mediated RTA repression. |
| Q26749612 | Cell Cycle Regulatory Functions of the KSHV Oncoprotein LANA |
| Q37204595 | Characterization of the interaction between latency-associated nuclear antigen and glycogen synthase kinase 3beta |
| Q35237492 | Chromatinization of the KSHV Genome During the KSHV Life Cycle |
| Q35046691 | Combination of arsenic and interferon-α inhibits expression of KSHV latent transcripts and synergistically improves survival of mice with primary effusion lymphomas |
| Q27680412 | Crystal Structure of the Gamma-2 Herpesvirus LANA DNA Binding Domain Identifies Charged Surface Residues Which Impact Viral Latency |
| Q38059746 | Cullin-RING Ligases as Attractive Anti-cancer Targets |
| Q34365216 | Cullins and Cancer |
| Q90625299 | Deficiency of HIF-1α enhances influenza A virus replication by promoting autophagy in alveolar type II epithelial cells |
| Q29615944 | Defining the role of hypoxia-inducible factor 1 in cancer biology and therapeutics |
| Q26766311 | Dendritic Cells under Hypoxia: How Oxygen Shortage Affects the Linkage between Innate and Adaptive Immunity |
| Q39744147 | Distinct p53, p53:LANA, and LANA complexes in Kaposi's Sarcoma--associated Herpesvirus Lymphomas |
| Q35570790 | Elongin C is a mediator of Notch4 activity in human renal tubule cells |
| Q55332047 | Endothelial cell malignancies: new insights from the laboratory and clinic. |
| Q28487983 | Epstein - Barr virus transforming protein LMP-1 alters B cells gene expression by promoting accumulation of the oncoprotein ΔNp73α |
| Q34102722 | Epstein-Barr virus nuclear antigen 3C stabilizes Gemin3 to block p53-mediated apoptosis |
| Q33638951 | Epstein-Barr virus-encoded EBNA1 inhibits the canonical NF-kappaB pathway in carcinoma cells by inhibiting IKK phosphorylation |
| Q38058483 | Functional characterization of SAG/RBX2/ROC2/RNF7, an antioxidant protein and an E3 ubiquitin ligase |
| Q37060535 | Genetic disruption of KSHV major latent nuclear antigen LANA enhances viral lytic transcriptional program |
| Q38068825 | Genome guardian p53 and viral infections |
| Q35137138 | HIF transcription factors, inflammation, and immunity |
| Q64067571 | How Viral and Intracellular Bacterial Pathogens Reprogram the Metabolism of Host Cells to Allow Their Intracellular Replication |
| Q39414795 | Human cytomegalovirus encoded chemokine receptor US28 activates the HIF-1α/PKM2 axis in glioblastoma cells. |
| Q36098917 | Human papillomavirus type 16 E7 oncoprotein associates with the cullin 2 ubiquitin ligase complex, which contributes to degradation of the retinoblastoma tumor suppressor |
| Q37711147 | Human viral oncogenesis: a cancer hallmarks analysis |
| Q34423461 | Human viruses and cancer. |
| Q33543092 | Hypoxia inactivates the VHL tumor suppressor through PIASy-mediated SUMO modification |
| Q34726144 | Hypoxia-Inducible Factor (HIF) as a Pharmacological Target for Prevention and Treatment of Infectious Diseases |
| Q27001095 | Hypoxia-inducible factor 1 and its role in viral carcinogenesis |
| Q42366342 | Hypoxia-inducible factor-1 alpha as a therapeutic target for primary effusion lymphoma. |
| Q38161730 | Hypoxia-inducible factors: mediators of cancer progression; prognostic and therapeutic targets in soft tissue sarcomas. |
| Q35034278 | IRF-4-mediated CIITA transcription is blocked by KSHV encoded LANA to inhibit MHC II presentation |
| Q91918273 | Identification of viral SIM-SUMO2-interaction inhibitors for treating primary effusion lymphoma |
| Q33743831 | Inhibition of KAP1 enhances hypoxia-induced Kaposi's sarcoma-associated herpesvirus reactivation through RBP-Jκ. |
| Q37897197 | Interference with p53 functions in human viral infections, a target for novel antiviral strategies? |
| Q42562294 | KSHV Induction of Angiogenic and Lymphangiogenic Phenotypes |
| Q49363063 | KSHV LANA upregulates the expression of epidermal growth factor like domain 7 to promote angiogenesis. |
| Q34774797 | KSHV LANA--the master regulator of KSHV latency |
| Q41662283 | KSHV and the Role of Notch Receptor Dysregulation in Disease Progression |
| Q37237030 | KSHV encoded LANA recruits Nucleosome Assembly Protein NAP1L1 for regulating viral DNA replication and transcription |
| Q36318661 | KSHV induces aerobic glycolysis and angiogenesis through HIF-1-dependent upregulation of pyruvate kinase 2 in Kaposi's sarcoma |
| Q38917974 | KSHV latent protein LANA2 inhibits sumo2 modification of p53. |
| Q28080937 | KSHV reactivation and novel implications of protein isomerization on lytic switch control |
| Q36087231 | KSHV-Mediated Regulation of Par3 and SNAIL Contributes to B-Cell Proliferation |
| Q93074235 | KSHV-encoded LANA protects the cellular replication machinery from hypoxia induced degradation |
| Q26738483 | Kaposi's Sarcoma Herpesvirus Genome Persistence |
| Q34186981 | Kaposi's Sarcoma Herpesvirus Upregulates Aurora A Expression to Promote p53 Phosphorylation and Ubiquitylation |
| Q38903379 | Kaposi's Sarcoma-Associated Herpesvirus Latency-Associated Nuclear Antigen Inhibits Major Histocompatibility Complex Class II Expression by Disrupting Enhanceosome Assembly through Binding with the Regulatory Factor X Complex |
| Q35689577 | Kaposi's Sarcoma-Associated Herpesvirus Latency-Associated Nuclear Antigen and Angiogenin Interact with Common Host Proteins, Including Annexin A2, Which Is Essential for Survival of Latently Infected Cells |
| Q39265271 | Kaposi's Sarcoma-Associated Herpesvirus Latency-Associated Nuclear Antigen: Replicating and Shielding Viral DNA during Viral Persistence |
| Q35192868 | Kaposi's Sarcoma-Associated Herpesvirus-Encoded Latency-Associated Nuclear Antigen Reduces Interleukin-8 Expression in Endothelial Cells and Impairs Neutrophil Chemotaxis by Degrading Nuclear p65 |
| Q47606321 | Kaposi's Sarcoma-Associated Herpesvirus: Epidemiology and Molecular Biology |
| Q36487309 | Kaposi's sarcoma and its associated herpesvirus |
| Q34426472 | Kaposi's sarcoma herpesvirus K15 protein contributes to virus-induced angiogenesis by recruiting PLCγ1 and activating NFAT1-dependent RCAN1 expression |
| Q39665994 | Kaposi's sarcoma-associated herpesvirus inhibits interleukin-4-mediated STAT6 phosphorylation to regulate apoptosis and maintain latency |
| Q40607781 | Kaposi's sarcoma-associated herpesvirus-encoded LANA can induce chromosomal instability through targeted degradation of the mitotic checkpoint kinase Bub1 |
| Q38859450 | Kaposi's sarcoma-associated herpesvirus-encoded LANA contributes to viral latent replication by activating phosphorylation of survivin |
| Q82344523 | Kaposi’s sarcoma-associated herpesvirus-encoded LANA positively affects on ubiquitylation of p53 |
| Q40698869 | Latency-Associated Nuclear Antigen E3 Ubiquitin Ligase Activity Impacts Gammaherpesvirus-Driven Germinal Center B Cell Proliferation |
| Q39852047 | Latency-associated nuclear antigen of Kaposi's sarcoma-associated herpesvirus (KSHV) upregulates survivin expression in KSHV-Associated B-lymphoma cells and contributes to their proliferation |
| Q33482148 | Malignant catarrhal fever of cattle is associated with low abundance of IL-2 transcript and a predominantly latent profile of ovine herpesvirus 2 gene expression |
| Q38934480 | Manipulation of ubiquitin/SUMO pathways in human herpesviruses infection |
| Q35010647 | Mechanisms of Kaposi's Sarcoma-Associated Herpesvirus Latency and Reactivation |
| Q53781024 | Metabolic reprogramming of Kaposi's sarcoma associated herpes virus infected B-cells in hypoxia |
| Q38674284 | Metabolic reprogramming: a hallmark of viral oncogenesis. |
| Q92238951 | Modulation of Angiogenic Processes by the Human Gammaherpesviruses, Epstein-Barr Virus and Kaposi's Sarcoma-Associated Herpesvirus |
| Q35124404 | Molecular Biology of Kaposi's Sarcoma-associated Herpesvirus and Related Oncogenesis |
| Q30387346 | Multiple oncogenic viruses identified in Ocular surface squamous neoplasia in HIV-1 patients |
| Q37840759 | NEDD8 Pathways in Cancer, Sine Quibus Non |
| Q28544735 | NEDDylation is essential for Kaposi's sarcoma-associated herpesvirus latency and lytic reactivation and represents a novel anti-KSHV target |
| Q38768252 | Nuclear translocation of HIF-1α induced by influenza A (H1N1) infection is critical to the production of proinflammatory cytokines |
| Q33282107 | Protein complexes associated with the Kaposi's sarcoma-associated herpesvirus-encoded LANA. |
| Q35664106 | Reactivation of the p53 pathway as a treatment modality for KSHV-induced lymphomas. |
| Q44703163 | Recruitment of the tumour suppressor protein p73 by Kaposi’s Sarcoma Herpesvirus latent nuclear antigen contributes to the survival of primary effusion lymphoma cells |
| Q35192690 | Ribosomal Protein S6 Interacts with the Latency-Associated Nuclear Antigen of Kaposi's Sarcoma-Associated Herpesvirus |
| Q64054763 | SOCS and Herpesviruses, With Emphasis on Cytomegalovirus Retinitis |
| Q60300525 | Safety and efficacy of an oncolytic viral strategy using bortezomib with ICE/R in relapsed/refractory HIV-positive lymphomas |
| Q58744059 | Shugoshin 1 is dislocated by KSHV-encoded LANA inducing aneuploidy |
| Q24309461 | Termination of NF-kappaB activity through a gammaherpesvirus protein that assembles an EC5S ubiquitin-ligase |
| Q83230171 | The CUL5 ubiquitin ligase complex mediates resistance to CDK9 and MCL1 inhibitors in lung cancer cells |
| Q61449826 | The Critical Role of Genome Maintenance Proteins in Immune Evasion During Gammaherpesvirus Latency |
| Q35140238 | The Internal Kaposi's Sarcoma-Associated Herpesvirus LANA Regions Exert a Critical Role on Episome Persistence |
| Q36099076 | The Kaposi's sarcoma-associated herpesvirus LANA protein stabilizes and activates c-Myc |
| Q26767186 | The Role of Gammaherpesviruses in Cancer Pathogenesis |
| Q35077558 | The Single RBP-Jκ Site within the LANA Promoter Is Crucial for Establishing Kaposi's Sarcoma-Associated Herpesvirus Latency during Primary Infection |
| Q37989143 | The Ubiquitin System and Kaposi’s Sarcoma-Associated Herpesvirus |
| Q41860564 | The latency-associated nuclear antigen interacts with MeCP2 and nucleosomes through separate domains |
| Q37380228 | The latency-associated nuclear antigen, a multifunctional protein central to Kaposi's sarcoma-associated herpesvirus latency |
| Q26749274 | The role of cullin 5-containing ubiquitin ligases |
| Q39329214 | The role of metabolic reprogramming in γ-herpesvirus-associated oncogenesis. |
| Q36057815 | The α2 helix in the DNA ligase IV BRCT-1 domain is required for targeted degradation of ligase IV during adenovirus infection |
| Q64247511 | Towards Better Understanding of KSHV Life Cycle: from Transcription and Posttranscriptional Regulations to Pathogenesis |
| Q37810431 | Tumor viruses and cancer biology: Modulating signaling pathways for therapeutic intervention |
| Q83165587 | Ubiquitin Family Members in the Regulation of the Tumor Suppressor p53 |
| Q34115236 | Ubiquitin/SUMO Modification Regulates VHL Protein Stability and Nucleocytoplasmic Localization |
| Q59351757 | Ubiquitination at the interface of tumor viruses and DNA damage responses |
| Q33814153 | Update on HHV-8-Associated Malignancies |
| Q35570286 | VHL negatively regulates SARS coronavirus replication by modulating nsp16 ubiquitination and stability |
| Q37301053 | Viral manipulation of DNA repair and cell cycle checkpoints |
| Q37871527 | Viruses as key regulators of angiogenesis |
| Q39858771 | X-box binding protein 1 contributes to induction of the Kaposi's sarcoma-associated herpesvirus lytic cycle under hypoxic conditions |
| Q39061575 | p53 tumor suppressor protein stability and transcriptional activity are targeted by Kaposi's sarcoma-associated herpesvirus-encoded viral interferon regulatory factor 3. |
Search more.